Mogrify

Reprogramming Health

Mogrify was founded in 2016, is headquartered in Cambridge, United Kingdom, lists 51–200 employees, and has $46.7M in recorded funding across 4 rounds.

Headquarters
Cambridge
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$46.7M
Last Round
$10.0M Extension RoundOct 2023
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Mogrify develops proprietary platforms that use big data and computational modeling to enable direct cellular reprogramming and maintain cell identity. It applies these platforms to develop in vivo reprogramming therapies for patients across otology, ophthalmology and diabetes. Its commercialization approach includes therapy development and co-development partnerships.

Summary

Mogrify is a Biotech company based in Cambridge, United Kingdom, founded in 2016. It lists 51–200 employees. It has raised $46.7M in total across 4 rounds, most recently a $10.0M Extension Round in Oct 2023. Investors include Astellas Venture Management, Parkwalk Advisors and Ahren Innovation Capital.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A Additional CloseOct 2023
$10.0M

Sign up to see all 4 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mogrify on Indexed.vc
<a href="https://indexed.vc/companies/mogrify"><img src="https://indexed.vc/api/badge/company/mogrify" alt="Mogrify on Indexed.vc" width="260" height="76" /></a>